The investment in iFactory Co., Ltd. aims to enhance production efficiency in Japan's pharmaceutical and chemical industries through advanced automated systems.
Target Information
iFactory Co., Ltd. is a leading company specializing in the development, manufacturing, and sales of modular fully automated continuous production systems tailored for the pharmaceutical and chemical industries. The company's innovative approach allows for streamlined production processes, enhancing efficiency and scalability for its clients.
By leveraging cutting-edge technology, iFactory aims to revolutionize the way pharmaceuticals and chemicals are produced, thus meeting the growing demands of a rapidly evolving market. Their systems are designed to meet stringent regulatory standards while maximizing productivity.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
Japan's pharmaceutical and chemical industries are among the most advanced globally, characterized by a strong emphasis on innovation and quality. Th
Similar Deals
ロッテベンチャーズ・ジャパン → 株式会社Dental Prediction
2024
N/A
invested in
株式会社iFactory
in 2025
in a Other VC deal